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Osteogenesis imperfecta type III is a heritable disorder leading to impaired 
connective tissue function in type I collagen containing tissues including 
bone fragility, blue-grey sclera, short stature, and hearing loss. Normal 
type I collagen is a heterotrimeric molecule containing two proα1(I) collagen 
chains and a similar but genetically distinct proα2(I) collagen chain. The 
osteogenesis imperfecta murine (oim) model mouse produces only homotrimeric 
type I collagen due to a single nucleotide deletion in the COL1A2 gene 
resulting in a non-functional proα2(I) collagen chain. The result is 
expression of an abnormal type I collagen molecule which leads to the above 
phenotype. This study is aimed at developing a methodology whereby dermal 
fibroblast cultures can be utilized for a variety of assays, including type I 
collagen RNA and protein quantification. For genotype identification, primers 
flanking the site of the single nucleotide deletion allow for differentiation 
of wild type, heterozygous and homozygous animals at the genomic level. Upon 
confirmation, skin was removed from both oim and wildtype mice and the dermal 
layer harvested. Fibroblasts originating from the dermal layer of each 
genotype were then cultured and grown to confluence as separate cultures and 
the RNA and/or protein harvested from both cell types. Total RNA was 
harvested using the Qiagen RNeasy kit and used to make cDNA, which was then 
used in conjunction with specific PCR primers to differentiate between 
wildtype and oim transcripts. For protein studies, the cells were treated 
with ascorbic acid to maximize the production of collagen prior to 
harvesting. Type I collagen expression was then confirmed via a western blot 
using a type I collagen-specific antibody. Initial results indicate the 
presence of both proα1(I) and proα2(I) collagen chains from harvested 
wildtype dermal fibroblasts, while media harvested from oim dermal 
fibroblasts indicated the presence of only the proα1(I) collagen chains. 
These results confirm the in vivo protein expression profile seen in skin of 
both oim and wildtype mice is exhibited in vitro in the respective dermal 
fibroblast cultures. These results will allow us to quantitate proα1(I) and 
proα2(I) collagen mRNA and protein expression levels. Future experiments will 
include the quantitation of type I collagen mRNA levels using RT-PCR, as well 
as the use of densitometry to quantitate type I collagen protein levels by 
western blot analysis. This in turn promises to provide insight into the 
mechanism of formation of abnormal type I collagen in the oim model mouse. 
